0 Commenti
0 condivisioni
324 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Advancements in Therapeutic Diets Across the Oncology Nutrition MarketThe Oncology Nutrition Market Demand is experiencing a significant surge, with a projected market size reaching USD 30.97 billion by 2035. This trend reflects a growing recognition among healthcare professionals and patients alike of the critical role nutrition plays in cancer treatment and recovery. As cancer rates continue to rise globally, the demand for specialized nutritional solutions...0 Commenti 0 condivisioni 301 Views 0 Anteprima
-
BRICS Cancer Chemotherapy Market USD 6,140.1 Million in 2024 Projected to Witness Rapid Oncology Expansion to USD 14,315.4 Million by 2031Growing awareness of early cancer diagnosis and treatment is contributing to higher therapy uptake rates. The BRICS Cancer Chemotherapy Market is estimated to record a CAGR of 12.9% from 2025 to 2031. Cancer chemotherapy remains one of the most widely used treatment modalities for managing various types of cancer, including lung, breast, colorectal, and hematological malignancies. In BRICS...0 Commenti 0 condivisioni 408 Views 0 Anteprima
-
Can Next-Generation Oncology Treatments Strengthen the Taxane Market?According to the latest report published by Data Bridge Market Research, the Taxane Market CAGR Value The Taxane Market was valued at USD 5.50 billion in 2025 and is projected to reach USD 8.31 billion by 2033, growing at a CAGR of 5.30% from 2026 to 2033. The world-class Taxane Market report analyses some of the challenges that Taxane Market industry may have to face during the...0 Commenti 0 condivisioni 343 Views 0 Anteprima
-
Epigenetics-Based Therapeutics Market to Advance as Precision Oncology Research Expands" According to the latest report published by Data Bridge Market Research, the Epigenetics-Based Therapeutics Market CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The Epigenetics-Based...0 Commenti 0 condivisioni 245 Views 0 Anteprima
-
Glioblastoma Multiforme Treatment Market Strengthens Through Breakthrough Oncology Innovations" According to the latest report published by Data Bridge Market Research, the Glioblastoma Multiforme Treatment Market CAGR Value Global glioblastoma multiforme treatment market size was valued at USD 3.09 billion in 2024 and is projected to reach USD 6.44 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032. An influential Glioblastoma Multiforme...0 Commenti 0 condivisioni 272 Views 0 Anteprima
-
How Is Demand for Precision Oncology Supporting the Asia-Pacific Tumor Ablation Market?According to the latest report published by Data Bridge Market Research, the Asia-Pacific Tumor Ablation Market CAGR Value The Asia-Pacific tumor ablation market size was valued at USD 2.36 billion in 2025 and is expected to reach USD 5.61 billion by 2033, at a CAGR of 11.45% during the forecast period The reliable Asia-Pacific Tumor Ablation Market research report includes...0 Commenti 0 condivisioni 253 Views 0 Anteprima
-
How The GCC Cancer Supportive Care Market Is Transforming Oncology CareInvestment in the GCC Cancer Supportive Care Market is indicative of a broader trend: the modernization of regional healthcare systems. With a rising burden of non-communicable diseases, governments are proactively allocating resources to strengthen oncology departments. This includes training specialized medical staff and procuring the latest supportive care medications that ensure patients...0 Commenti 0 condivisioni 186 Views 0 Anteprima
-
Hyper Personalized Medicine Market Advances Through Precision Oncology ApplicationsThe global Hyper Personalized Medicine Market is rapidly evolving as emerging technologies enable healthcare providers to deliver highly targeted therapies tailored to individual biological characteristics. According to Polaris Market Research, the market reached USD 2,256.42 billion in 2023 and is forecast to grow to USD 6,333.03 billion by 2032, expanding at a CAGR of 12.2%. The increasing...0 Commenti 0 condivisioni 259 Views 0 Anteprima
-
Keytruda Market: Oncology Innovation & Forecast 2024–2034Market Scope The Keytruda Market is witnessing significant growth as immunotherapy continues to transform modern cancer treatment. Keytruda (pembrolizumab), developed by Merck & Co., Inc., is one of the world's leading immune checkpoint inhibitors targeting the PD-1 pathway. It has become a preferred treatment option for a wide range of cancers, including non-small cell lung...0 Commenti 0 condivisioni 323 Views 0 Anteprima
-
Latin America Cancer Hormone Therapy Market USD 1,641.9 Million in 2024 Projected to Witness Rapid Oncology Market Expansion to USD 3,091.7 Million by 2031Ongoing clinical research and therapeutic innovation are strengthening the oncology treatment landscape in the region. The Latin America cancer hormone therapy market is estimated to record a CAGR of 9.5% from 2025 to 2031. Cancer hormone therapy is an essential component of oncology treatment used primarily for hormone-sensitive cancers such as breast, prostate, and endometrial cancers. In...0 Commenti 0 condivisioni 345 Views 0 Anteprima
-
Middle East and Africa Cancer Hormone Therapy Market USD 841.3 Million in 2024 Projected to Witness Strong Oncology Treatment Demand Growth to USD 1,468.2 Million by 2031The Middle East and Africa cancer hormone therapy market is expanding due to rising cancer incidence and increasing adoption of advanced oncology treatments across the region. The Middle East and Africa cancer hormone therapy market is estimated to record a CAGR of 8.3% from 2025 to 2031. The demand for cancer hormone therapy in the Middle East and Africa is being driven primarily by the...0 Commenti 0 condivisioni 418 Views 0 Anteprima
-
Cancer Immunotherapy Market Growth Across Solid Tumors and Hematological MalignanciesThe global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...0 Commenti 0 condivisioni 459 Views 0 Anteprima
-
How Is Genetic Risk Awareness Driving the North America Hereditary Cancer Testing Market?According to the latest report published by Data Bridge Market Research, the North America Hereditary Cancer Testing Market CAGR Value The North America hereditary cancer testing market size was valued at USD 3.39 billion in 2025 and is expected to reach USD 9.20 billion by 2033, at a CAGR of 13.3% during the forecast period Market research analysis and data in this North...0 Commenti 0 condivisioni 372 Views 0 Anteprima
-
mTOR Inhibitor Oncology Drug Market Gains Momentum with Growing Targeted Cancer Therapy Pipeline" According to the latest report published by Data Bridge Market Research, the mTOR Inhibitor Oncology Drug Market CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Market research analysis and data...0 Commenti 0 condivisioni 224 Views 0 Anteprima
-
Oncology Based Molecular Diagnostics Market Outlook: Growing Adoption of Personalized Cancer TherapiesThe Oncology Based Molecular Diagnostics Market is rapidly evolving as precision medicine reshapes the global approach to cancer diagnosis and treatment. Molecular diagnostic technologies are enabling healthcare professionals to identify cancer-specific genetic alterations, detect tumors at earlier stages, and develop personalized treatment strategies based on individual patient...0 Commenti 0 condivisioni 369 Views 0 Anteprima
-
Radiopharmaceutical Oncology Therapy Market Gains Traction with Advances in Targeted Radiation Treatment" According to the latest report published by Data Bridge Market Research, the Radiopharmaceutical Oncology Therapy Market CAGR Value The global radiopharmaceutical oncology therapy market size was valued at USD 5.43 billion in 2025 and is expected to reach USD 15.92 billion by 2033, at a CAGR of 14.40% during the forecast period To impart a...0 Commenti 0 condivisioni 172 Views 0 Anteprima
-
Subcutaneous Oncology Biologic Drug Market Grows on Shift Toward Patient-Friendly Cancer Treatment Delivery" According to the latest report published by Data Bridge Market Research, the Subcutaneous Oncology Biologic Drug Market CAGR Value The global Subcutaneous Oncology Biologic Drug market size was valued at USD 15.78 billion in 2025 and is expected to reach USD 34.82 billion by 2033, at a CAGR of 10.40% during the forecast period This Subcutaneous...0 Commenti 0 condivisioni 246 Views 0 Anteprima
Pagine in Evidenza
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek